Skip to main content
. 2022 Aug 10;7(9):905–912. doi: 10.1001/jamacardio.2022.2496

Figure 4. Clinical Decision-making in Regard to Medical Therapy and Palliative Care Referral According to Alert Group.

Figure 4.

Discharge use of guideline-directed medical therapy (GDMT) in patients with left ventricular ejection fraction (LVEF) of 40% or less (A) and palliative care referral (B). There was no evidence of differences in discharge prescription of heart failure medical therapies in patients with LVEF of 40% or less or referral to palliative care. ACE-I indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor neprilysin inhibitor; MRA, magnetic resonance angiography; SGLT2i, sodium/glucose cotransporter 2 inhibitor.